LGND : Insider Transactions for Ligand Pharmaceuticals Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Ligand Pharmaceuticals Inc (LGND)

$85.05

1.09 (1.3%) as of 4:30 Fri 5/31

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

18,090,000

Market Cap:

1.54(B)

Last Volume:

562,071

Avg Vol:

560,537

52 Week Range:

$49.57 - $89.2

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Drug Manufacturers - Other

Member Indexes:

	NASDAQ BIOTECHNOLOGY		NASDAQ COMPOSITE
	NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 1017

Guru Rank Value : 0

Guru Occurances : 1


6 Months 1 Year 2 Year

Company Profile Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Co. employs research technologies such as antibody discovery technologies, ion channel discovery technology, Pseudomonas fluorescens protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. Co.'s collaboration partners and licensees have programs in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	4,000	4,000
Total Buy Value	$0	$0	$237,529	$237,529
Total People Bought	0	0	1	1
Total Buy Transactions	0	0	1	1
Total Shares Sold	43,718	43,858	43,858	89,114
Total Sell Value	$3,691,256	$3,703,640	$3,703,640	$7,118,774
Total People Sold	5	5	5	7
Total Sell Transactions	8	9	9	19
End Date	2024-03-03	2023-12-01	2023-06-02	2022-06-02

Adjust Filter Settings

Records found: 534

Page 16 of 22

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Director

– • –

2017-05-25

4

A

$0.00

$0

D/D

666

59,625

-

Foehr Matthew W

President and COO

• – –

2017-05-15

4

OE

$9.97

$21,934

D/D

2,200

94,920

-

Foehr Matthew W

President and COO

• – –

2017-05-12

4

S

$112.20

$630,650

D/D

(5,621)

92,720

-

Foehr Matthew W

President and COO

• – –

2017-05-12

4

OE

$9.97

$56,041

D/D

5,621

98,341

-

Director

– • –

2017-05-12

4

S

$111.87

$1,631,334

I/I

(14,582)

116,651

-

Director

– • –

2017-05-11

4

S

$110.04

$2,494,025

I/I

(22,665)

131,233

-

Chief Executive Officer

• • –

2017-03-20

4

AS

$109.10

$436,400

D/D

(4,000)

139,171

-

Chief Executive Officer

• • –

2017-03-08

4

D

$106.92

$157,493

D/D

(1,473)

143,171

-

Chief Executive Officer

• • –

2017-03-08

4

OE

$10.05

$157,534

D/D

15,675

144,644

-

Chief Executive Officer

• • –

2017-03-08

4

S

$107.06

$428,240

D/D

(4,000)

128,969

-

Foehr Matthew W

President and COO

• – –

2017-03-03

4

OE

$9.97

$19,940

D/D

2,000

92,720

-

Foehr Matthew W

President and COO

• – –

2017-03-02

4

S

$103.39

$711,214

D/D

(6,879)

90,720

-

Foehr Matthew W

President and COO

• – –

2017-03-02

4

OE

$9.97

$68,584

D/D

6,879

97,599

-

Director

– • –

2017-02-28

4

S

$107.58

$753,060

I/I

(7,000)

153,898

-

Director

– • –

2017-02-27

4

S

$106.00

$2,650,000

I/I

(25,000)

160,898

-

Chief Executive Officer

• • –

2017-02-24

4

A

$0.00

$0

D/D

19,392

132,969

-

Chief Executive Officer

• • –

2017-02-24

4

D

$100.38

$480,118

D/D

(4,783)

122,745

-

Foehr Matthew W

President and COO

• – –

2017-02-24

4

A

$0.00

$0

D/D

12,783

90,720

-

Foehr Matthew W

President and COO

• – –

2017-02-24

4

D

$100.38

$274,339

D/D

(2,733)

83,176

-

Berkman Charles S

VP, Gen. Counsel & Secretary

• – –

2017-02-24

4

A

$0.00

$0

D/D

4,878

42,805

-

Chief Executive Officer

• • –

2017-02-15

4

D

$104.28

$448,821

D/D

(4,304)

118,360

-

Foehr Matthew W

President and COO

• – –

2017-02-15

4

D

$104.28

$246,831

D/D

(2,367)

80,670

-

Korenberg Matthew E

VP, Finance and CFO

• – –

2016-12-30

4

A

$86.37

$3,455

D/D

40

10,106

-

Director

– • –

2016-12-28

4

GD

$0.00

$0

D/D

48

70,141

-

Director

– • –

2016-11-25

4

S

$106.96

$372,007

I/I

(3,478)

185,898

-

534 Records found	Previous 10 11 12 13 14 15 16 17 18 19 Next	Page 16 of 22

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.